Clinical Trial Update: Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy [Phase 3]

View source ↗

Summary

A Phase 3 trial compares Bictegravir/Lenacapavir to current therapy in people with HIV-1 who are successfully treated with Biktarvy. The study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)
• Bictegravir/Lenacapavir (bictegravir/lenacapavir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-infection | Phase 3 | Status: ACTIVE_NOT_RECRUITING